Pfizer COVID-19 vaccine appointments are available to our patients. Sign up for Connect today to schedule your vaccination.
This is a prospective, multi-center, observational study designed to determine if specific agents used for treatment of inflammatory bowel disease (IBD) are associated with the development of new or recurrent cancer in patients with IBD and a history of cancer.
Commitments for enrollment include:
Note: No invasive tests (blood tests, x-rays, endoscopies, or other procedures) will be performed for the purpose of this research study. No drugs or devices will be administered to you as part of this study.
Exclusion Criteria